Mehdikhani F, Hajimehdipoor H, Tansaz M, Maresca M, Rajabi S
Biomolecules. 2025; 15(2).
PMID: 40001571
PMC: 11852507.
DOI: 10.3390/biom15020268.
Ear P, Marinoni I, Dayton T, Guenter R, Quelle D, Battistella A
Endocr Oncol. 2025; 4(1):e240055.
PMID: 39822778
PMC: 11737514.
DOI: 10.1530/EO-24-0055.
Sun Y, Yee E, Fujiwara Y, Dickinson K, Guo Y, Sun Z
J Immunother Cancer. 2025; 13(1.
PMID: 39805660
PMC: 11749055.
DOI: 10.1136/jitc-2024-010554.
Bakiri L, Tichet M, Marques C, Thomsen M, Allen E, Allen E
Dis Model Mech. 2025; 18(1).
PMID: 39745082
PMC: 11789939.
DOI: 10.1242/dmm.052130.
Jeevanandam A, Yin Z, Connolly K, Joshi N
Methods Mol Biol. 2024; 2864:57-76.
PMID: 39527217
DOI: 10.1007/978-1-0716-4184-2_4.
Milestones in tumor vascularization and its therapeutic targeting.
de Palma M, Hanahan D
Nat Cancer. 2024; 5(6):827-843.
PMID: 38918437
DOI: 10.1038/s43018-024-00780-7.
Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.
Fuentes M, Lu X, Flores N, Hausmann S, Mazur P
Sci Rep. 2024; 14(1):8510.
PMID: 38609433
PMC: 11014914.
DOI: 10.1038/s41598-024-58874-2.
Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy.
Scalia P, Marino I, Asero S, Pandini G, Grimberg A, El-Deiry W
Biomedicines. 2024; 12(1).
PMID: 38255147
PMC: 10813354.
DOI: 10.3390/biomedicines12010040.
Genetically modified mice as a tool for the study of human diseases.
Bruter A, Varlamova E, Okulova Y, Tatarskiy V, Silaeva Y, Filatov M
Mol Biol Rep. 2024; 51(1):135.
PMID: 38236499
DOI: 10.1007/s11033-023-09066-0.
Cancer Evolution: A Multifaceted Affair.
Ciriello G, Magnani L, Aitken S, Akkari L, Behjati S, Hanahan D
Cancer Discov. 2023; 14(1):36-48.
PMID: 38047596
PMC: 10784746.
DOI: 10.1158/2159-8290.CD-23-0530.
Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment.
Lee E, OKeefe S, Leong A, Park H, Varadarajan J, Chowdhury S
J Clin Invest. 2023; 133(20).
PMID: 37843277
PMC: 10575726.
DOI: 10.1172/JCI167994.
Depletion of slow-cycling PDGFRαADAM12 mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.
Di Carlo S, Raffenne J, Varet H, Ode A, Cabrerizo Granados D, Stein M
Nat Immunol. 2023; 24(11):1867-1878.
PMID: 37798557
PMC: 10602852.
DOI: 10.1038/s41590-023-01642-7.
Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors.
Chen Y, Yamamoto T, Takahashi Y, Moro T, Tajima T, Sakaguchi Y
Cell Death Dis. 2023; 14(9):597.
PMID: 37679316
PMC: 10484927.
DOI: 10.1038/s41419-023-06123-1.
Plexins as Regulators of Cancer Cell Proliferation, Migration, and Invasivity.
Toledano S, Neufeld G
Cancers (Basel). 2023; 15(16).
PMID: 37627074
PMC: 10452846.
DOI: 10.3390/cancers15164046.
Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis.
Egidi M, Krug S, Haybaeck J, Michl P, Griesmann H
Br J Cancer. 2023; 129(8):1225-1237.
PMID: 37620408
PMC: 10575939.
DOI: 10.1038/s41416-023-02389-6.
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.
Forsythe S, Pu T, Andrews S, Madigan J, Sadowski S
Cancers (Basel). 2023; 15(15).
PMID: 37568572
PMC: 10416968.
DOI: 10.3390/cancers15153756.
A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective.
Werle S, Ikonomi N, Lausser L, Kestler A, Weidner F, Schwab J
NPJ Syst Biol Appl. 2023; 9(1):22.
PMID: 37270586
PMC: 10239456.
DOI: 10.1038/s41540-023-00283-8.
Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives.
Naba A
Mol Cell Proteomics. 2023; 22(4):100528.
PMID: 36918099
PMC: 10152135.
DOI: 10.1016/j.mcpro.2023.100528.
Novel Mouse Models for Cancer Immunology.
Connolly K, Fitzgerald B, Damo M, Joshi N
Annu Rev Cancer Biol. 2023; 6(1):269-291.
PMID: 36875867
PMC: 9979244.
DOI: 10.1146/annurev-cancerbio-070620-105523.
Recent progress of experimental model in pancreatic neuroendocrine tumors: drawbacks and challenges.
Wang Y, Wang F, Qin Y, Lou X, Ye Z, Zhang W
Endocrine. 2023; 80(2):266-282.
PMID: 36648608
DOI: 10.1007/s12020-023-03299-6.